2. Nishimura R.A., Otto C.M., Bonow R.O., Carabello B.A., Erwin J.P., Guyton R.A., O’Gara P.T., Ruiz C.E., Skubas N.J., Sorajja P., Sundt Th.M., Thomas J.D. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:2440–2492.

3. Vahanian A., Alfieri O., Andreotti F., Antunes M.J., Barón-Esquivias G., Baumgartner H., Borger M.A., Carrel T.P., De Bonis M., Evangelista A., Falk V., Iung B., Lancellotti P., Pierard L., Price S., Schäfers H-J., Schuler G., Stepinska J., Swedberg K., Takkenberg J., Oppell Von U.O., Windecker S., Zamorano J.L., Zembala M. Guidelines on the management of valvular heart disease (version 2012). Eur. Heart J. 2012;33:2451–2496.

4. Pibarot P., Dumesnil J.G. Improving assessment of aortic stenosis. J. Am. Coll. Cardiol. 2012;60:169–180.

5. Rajani R., Hancock J., Chambers J.B. The art of assessing aortic stenosis. Heart. 2012;(4):98.

6. Carabello B.A., Blase A. «What Is Severe Aortic Stenosis and Why Do People Die From It?» JACC: Cardiovascular Imaging. 2016;21:806–808.

7. Saikrishnan N., Kumar G., Sawaya F.J. et al. Accurate assessment of aortic stenosis: a review of diagnostic modalities and hemodynamics. Circulation. 2014;129(2):244–253.

8. Dumesnil J.G., Pibarot Ph., Carabello B. Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment. European Heart Journal. 2010;31:281–289.

9. Bhattacharyya S., Mittal T., Abayalingam M. et al. Classification of Aortic Stenosis by Flow and Gradient Patterns Provides Insights into the Pathophysiology of Disease. Angiology. 2016;67(7):664–649.

10. Chambers J.B. Aortic stenosis. Eur. J. Echocardiogr. 2009;10:i11–19.

11. Lentine K.L., Costa S.P., Weir M.R., Robb J.F., Fleisher L.A., Kasiske B.L., Carithers R.L., Ragosta M., Bolton K., Auerbach A.D., Eagle K.A. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J. Am. Coll. Cardiol. 2012;60:434–480.

12. Bhatti N.K., Galougahi K., Paz Y., Nazif T., Moses J.W., Leon M.B., Stone G.W., Kirtane A.J., Karmpaliotis D., Bokhari S., Hardy M.A., Dube G., Mohan S., Ratner L.E., Cohen D.J., Ali Z.A. Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J. Am. Heart Assoc. 2016;5(8):pii:e003648.

13. Aikawa E., Schoen F.J. In: Calcific and degenerative heart valve disease, in Cellular and molecular pathobiology of cardiovascular disease. Stone J., Homeister J.M., Willis M.S., editors. 2014;161–181.

14. Osnabrugge R.L., Mylotte D., Head S.J., Van Mieghem N.M., Nkomo V.T., LeReun C.M., Bogers A.J., Piazza N., Kappetein A.P. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J. Am. Coll. Cardiol. 2013;62:1002–1012.

15. Eveborn G.W., Schirmer H., Heggelund G., Lunde P., Rasmussen K. The evolving epidemiology of valvular aortic stenosis: the Tromsø Study. Heart 2013;99:396–400.

16. Rattazzi M., Bertacco E., Del Vecchio A., Puato M., Faggin E., Pauletto P. Aortic valve calcification in chronic kidney disease. Nephrol. Dial. Transplant. 2013;28:2968–2976.

17. Shroff R., Long D.A., Shanahan C. Mechanistic insights into vascular calcification in CKD. J. Am. Soc. Nephrol. 2013;24:179–189.

18. Волгина Г., Селезнев Д., Балкарова О., Ловчинский Е. Внекостная кальцификация у пациентов с хронической болезнью почек. Врач. 2012;7;2–8.

19. Шило В.Ю., Гендлин Г.Е., Перекокин Ю.Н., Денисов А.Ю., Сторожаков Г.Е. Кальциноз структур сердца у больных на программном гемодиализе (ГД). Нефрология и диализ. 2001;3(2):160–168.

20. Urena P., Malergue M.C., Goldfarb B., Prieur P., Guédon-Rapoud C., Pétrover M. Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors. Nephrol. 1999;20:217–225.

21. Maher E.R., Pazianas M., Curtis J.R. Calcific aortic stenosis: a complication of chronic uraemia. Nephrol. 1987;47:119–122.

22. Umana E., Ahmed W., Alpert M.A. Valvular and perivalvular abnormalities in end-stage renal disease. Am. J. Med. Sci. 2003;325:237–242.

23. Straumann E., Meyer B., Misteli M. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br. Heart J. 1992;67:236–239.

24. Braun J., Oldendorf M., Moshage W. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am. J. Kidney Dis. 1996;27:394–401.

25. Ribeiro S., Ramos A., Brandao A. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol. Dial. Transplant. 1998;13:2037–2040.

26. Ventura J.E., Tavella N., Romero C. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrol. Dial. Transplant. 2002;17;1795–1810.

27. Raggi P., Boulay A., Chasan-Taber S. Amin N., Dillon M., Burke S.K., Chertow G.M. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J. Am. Coll. Cardiol. 2002;39:695–701.

28. Schonenberger A., Winkelspecht B., Kohler H., Girndt M. High prevalence of aortic valve alterations in haemodialysis patients is associated with signs of chronic inflammation. Nephron. Clin. Pract. 2004;96:48–55.

29. Varma R., Aronow W.S., McClung J.A., Garrick R., Vistainer P.F., Weiss M.B., elkin R.N. Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. Am. J. Cardiol. 2005;95:742–753.

30. Tarrass F., Benjelloun M., Zamd M., Medkouri G., Hachim K., Benghanem M.G., Ramdani B. Heart valve calcifications in patients with end-stage renal disease: analysis for risk factors. Nephrol. (Carlton). 2006;11:494–496.

31. Holden R.M., Sanfilippo A.S., Hopman W.M., Zimmerman D., Garland J.S., Morton A.R. Warfarin and aortic valve calcification in hemodialysis patients. J Nephrol. 2007;20:417–422.

32. Ikee R., Honda K., Ishioka K., Oka M., Maesato K., Moriya H., Hidaka S., Ohtake T., Kobayashi S. Differences in associated factors between aortic and mitral valve calcification in hemodialysis. Hypertens. Res. 2010;33:622–626.

33. Zentner D., Hunt D., Chan W. Prospective evaluation of aortic stenosis in end-stage kidney disease: a more fulminant process? Nephrol. Dial. Transplant. 2011;26:1651–1655.

34. Rosenhek R., Binder T., Porenta G. et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000;343:611–617.

35. Kume T., Kawamoto T., Akasaka T., Lang I., Christ G., Schemper M., Maurer G., Baumgartner H. Rate of progression of valvular aortic stenosis in patients undergoing dialysis. J. Am. Soc. Echocardiogr. 2006;19:914–918.

36. Wang A.Y., Wang M., Woo J., Lam C.W., Li P.K., Lui S.F., Sanderson J.E. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J. Am. Soc. Nephrol. 2003;14:159–168.

37. Raggi P., Bellasi A., Gamboa C., Ferramosca E., Ratti C., Block G.A., Muntner P. All-cause mortality in hemodialysis patients with heart valve calcification. Clin. J. Am. Soc. Nephrol. 2011;6:1990–1995.

38. Ori Y., Korzets A., Katz M., Perek Y., Zahavi I., Gafter U. Haemodialysis arteriovenous access-a prospective haemodynamic evaluation. Nephrol. Dial. Transplant. 1996;11(1):94–97.

39. Savage M.T., Ferro C.J., Sassano A., Tomson C.R. The impact of arteriovenous fistula formation on central hemodynamic pressures in chronic renal failure patients: a prospective study. Am. J. Kidney Dis. 2002;40:753–759.

40. Mehta P.A., Dubrey S.W. High output heart failure. Q. J. Med. 2009;102:235–241.

41. Anand I.S., Florea V.G. High Output Cardiac Failure. Curr. Treat. Options Cardiovasc. Med. 2001;3(2):151–159.

42. Alkhouli M., Sandhu P., Boobes K., Hatahet K., Raza F., Boobes Y. Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease. Nefrol. 2015;35:234–245.

43. MacRae J.M., Pandeya S., Humen D.P., Krivitski N., Lindsay R.M. Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am. J. Kidney Dis. 2004;43:e17–e22.

44. MacRae J.M., Levin A., Belenkie I. The cardiovascular effects of arteriovenous fistulas in chronic kidney disease: a cause for concern? Semin Dial. 2006;19(5):349–352.

45. Basile C., Lomonte C., Vernaglione L., Casucci F., Antonelli M., Losurdo N. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol. Dial. Transplant. 2008;23(1):282–287.

46. Unger P., Xhaët O., Wissing K.M., Najem B., Dehon P., van de Borne P. Arteriovenous fistula closure after renal transplantation: a prospective study with 24-hour ambulatory blood pressure monitoring. Transplantation. 2008;85(3):482–485.

47. Briand M., Dumesnil J.G., Kadem L., Tongue A.G., Rieu R., Garcia D., Pibarot P. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J. Am. Coll. Cardiol. 2005;46:291–298.

48. Hachicha Z., Dumesnil J.G., Pibarot P. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J. Am. Coll. Cardiol. 2009;54:1003–1011.

49. Lancellotti P., Donal E., Magne J., Moonen M., O’Connor K., Daubert J.C., Pierard L.A. Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay. Heart. 2010;96:1364–1371.

50. Mise N., Uchida L., Tanaka M., Nakajima H., Sugimoto T. Acute systemic hypotension after arteriovenous fistula construction in a patient with severe aortic stenosis. Clin. Exp. Nephrol. 2011;15(5):788–790.

51. Ennezat P.V., Maréchaux S., Pibarot P. From excessive high-flow, high-gradient to paradoxical low-flow, low-gradient aortic valve stenosis: hemodialysis arteriovenous fistula model. Cardiol. 2010;116(1):70–72.

52. Yigla M., Fruchter O., Aharonson D., Yanay N., Reisner S.A., Lewin M., Nakhoul F. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int. 2009;75:969–975.

53. Navaneethan S.D., Roy J., Tao K., Brecklin C.S., Chen J., Deo R., Flack J.M., Ojo A.O., Plappert T.J., Raj D.S., Saydain G., Sondheimer J.H., Sood R., Steigerwalt S.P., Townsend R.R., Dweik R.A., Rahman M. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD. J. Am. Soc. Nephrol. 2016;27(3):877–886.

54. Han J.H., Han J.S., Kim J.E., Doh F.M., Koo H.M., Kim C.H., Lee M.J., Oh H.J., Park J.T., Han S.H., Ryu D.R., Yoo T.H., Kang S.W. Diastolic dysfunction is an independed predictor of cardiovascular events in incident dialysis patients with preserved systolic function. PLoS ONE.2015;dDoi:10.1371.

55. Malouf J.F., Enriquez-Sarano M., Pellikka P.A., Oh J.K., Bailey K.R., Chandrasekaran K., Mullany C.J., Tajik A.J. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. Cardiol. 2002;40:789–795.